The mycobiome – a friendly cross-talk between fungal colonizers and their host

• Autorzy: Dworecka-Kaszak B. , Dabrowska I. , Kaszak I.
• Języki publikacji: EN

Abstrakty

EN

The organisms colonizing a living host create together with their host a holobiome. The holobioms are networks of mutualistic interactions between host`s cells and microorganisms communities. The fungi are among these microorganisms and have been also well known to infect human and animals. These organisms are associated with a wide range of diseases as superficial or systemic mycoses. Fungi as colonizers can also modify host physiology and metabolism, energy acquisition, vitamin-cofactor availability, development and function of immune system, and even host behavior. The objective of this review is to familiarize with recent data concerning the role of fungi creating mammalian mycobiome in the maintenance of the host health status.

• Wydawca: -
• Czasopismo: Annals of Parasitology
• Rocznik: 2016
• Tom: 62
• Numer: 3
• Opis fizyczny: p.175–184,fig.,ref.

Twórcy

autor

Dworecka-Kaszak B.

• Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

autor

Dabrowska I.

• Department of Preclinical Sciences, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Ciszewskiego 8, 02-786 Warsaw, Poland

autor

Kaszak I.

• Department of Small Animal Diseases with Clinic, Faculty of Veterinary Medicine, Warsaw University of Life Sciences - SGGW, Nowoursynowska 159C, 02-776 Warsaw, Poland

Bibliografia

• [1] Günther C., Josenhans C., JanWehkamp J. 2016. Crosstalk between microbiota, pathogens and the innate immune responses. International Journal of Medical Microbiology. doi:10.1016/j.ijmm.2016.03.003.
• [2] Seed P.C. 2014. The Human Mycobiome. Cold Spring Harbor Perspectives in Medicine 5: a019810.doi:10.1101/cshperspect.a019810.
• [3] Oever J.T., Netea M.G. 2014. The bacteriomemycobiome interaction and antifungal host defense. European Journal of Immunology 11: 3182-3191.
• [4] Lederberg J, McCray AT. 2001. ‘Ome Sweet ‘Omics –a genealogical treasury of words. The Scientist 15: 8.
• [5] Hoffmann C., Dollive S., Grunberg S., Chen J., Li H., Wu G.D., Lewis J.D., Bushman F.D. 2013. Archaea and fungi of the human gut microbiome: Correlations with diet and bacterial residents. PLOS ONE 8: e66019.
• [6] Romani L., Zelante T., Palmieri M., Napolioni V., Picciolini M., Velardi A., Aversa F., Puccetti P. 2015. The cross-talk between opportunistic fungi and the mammalian host via microbiota’s metabolism. Seminars in Immunopathology 37: 163-171.
• [7] Chow J., Tang H., Mazmanian S.K. 2011. Pathobionts of the gastrointestinal microbiota and inflammatorydisease. Current Opinion in Immunology 23: 473-480.
• [8] Salzman N.H. 2010. Paneth cell defensins and the regulation of the microbiome: detente at mucosal surfaces. Gut Microbes 1: 401-406.
• [9] Louis P., Hold G.L., Flint H.J. 2014. The gut microbiota, bacterial metabolites and colorectal cancer. Nature Reviews Microbiology 12: 661-672.
• [10] Monaghan T.M., Cockayne A., Mahida Y.R. 2015. Pathogenesis of Clostridium difficile infection and its potential role in inflammatory bowel disease. Inflammatory Bowel Diseases 21: 1957-1966.
• [11] Nell S., Suerbaum S., Josenhans C. 2010. The impact of the microbiota on the pathogenesis of IBD: lessons from mouse infection models. Nature Reviews Microbiology 8: 564-577.
• [12] Cui L., Morris A., Ghedin E. 2013. The human mycobiome in health and disease. Genome Medicine 5: 63.
• [13] Stefanini I., Dapporto L., Legras J.L., Calabretta A., Di Paola M., De Filippo C., Viola R., Capretti P., Polsinelli M., Turillazzi S., Cavalieri D. 2012. Role of social wasps in Saccharomyces cerevisiae ecology and evolution. Proceedings of the National Academy of Sciences 109: 13398-13403.
• [14] Peleg A.Y., Hogan D.A., Mylonakis E. 2010. Medically importantbacterial-fungal interactions. Nature Reviews Microbiology 8: 340-349.
• [15] Ott S.J., Kuhbacher T., Musfeldt M., Rosenstiel P., Hellmig S., Rehman A., Drews O., Weichert W., Timmis K.N., Schreiber S. 2008. Fungi and inflammatory bowel diseases: alterations of composition and diversity. Scandinavian Journal of Gastroenterology 43: 831-841.
• [16] Scupham A.J., Presley L.L., Wei B., Bent E., Griffith N., McPherson M., Zhu F., Oluwadara O., Rao N., Braun J., Borneman J. 2006. Abundant and diverse fungalmicrobiota in the murine intestine. Applied and Environmental Microbiology 72: 793-801.
• [17] Schaubeck M., Clavel T., Calasan J., Lagkouvardos I., Haange S.B., Jehmlich N., Basic M., Dupont A., Hornef M., Bergen M., Bleich A., Haller D. 2016. Dysbiotic gut microbiota causes transmissible Crohn’s disease-like ileitis independent of failure in antimicrobial defence. Gut 65: 225-237.
• [18] Jouault T., Sarazin A., Martinez-Esparza M., Fradin C., Sendid B., Poulain D. 2009. Host responses to a versatile commensal: PAMPs and PRRs interplay leading to tolerance or infection by Candida albicans. Cellular Microbiology 11: 1007-1015.
• [19] Rizzetto L., De Filippo C., Cavalieri D. 2014. Richness and diversity of mammalian fungal communities shape innate and adaptive immunity in health and disease. European Journal of Immunology 44: 3166-3181.
• [20] Rolig A.S.R., Parthasarathy A.R., Burns B.J., Bohannan K. 2015. Guillemin Individual members of the microbiota disproportionately modulate host innate immune responses. Cell Host Microbe 18: 613-620.
• [21] Lai Y., Di Nardo A., Nakatsuji T., Leichtle A., Yang Y., Cogen A.L., Wu Z.R., Hooper L.V., von Aulock S., Radek K.A., Huang C.M., Ryan A.F., Gallo R.L. 2009. Commensal bacteria regulate Toll-like receptor 3-dependent inflammation after skin injury. Nature Medicine 15: 1377-1382.
• [22] Huang W., Na L., Fidel P.L., Schwarzenberger P. 2004. Requirement ofinterleukin-17A for systemic anti-Candida albicans host defense in mice. Journal of Infectious Diseases 190: 624-631.
• [23] Ostaff M.J., Stange E.F., Wehkamp J. 2013. Antimicrobial peptides and gut microbiota in homeostasis and pathology. EMBO Molecular Medicine 5: 1465-1483.
• [24] Qin J., Li R., Raes J., Arumugam M., Burgdorf K.S., Manichanh C., Nielsen T., Pons N., Levenez F., Yamada T. 2010. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 464: 59-65.
• [25] Swiatczak B., Cohen I.R. 2015. Gut feelings of safety: tolerance to the microbiota mediated by innate immune receptors. Microbiology and Immunology 59: 573-585.
• [26] Zeeuwen P.L., Kleerebezem M., Timmerman H.M., Schalkwijk J. 2013. Microbiome and skin diseases. Current Opinion in Allergy and Clinical Immunology 13: 514-520.
• [27] Paulino L.C., Tseng C.H., Strober B.E., Blaser M.J. 2006. Molecular analysis of fungal microbiota in samples from healthy human skin and psoriatic lesions. Journal of Clinical Microbiology 44: 2933-2941.
• [28] Heath W.R., Carbone F.R. 2013. The skin-resident and migratory immune system in steady state and memory: innate lymphocytes, dendritic cells and T cells. Nature Immunology 14: 978-985.
• [29] Kuo I.H., Yoshida T., De Benedetto A., Beck L.A. 2013. The cutaneous innate immune response in patients with atopic dermatitis. Journal of Allergy and Clinical Immunology 131: 266-278.
• [30] Seneschal J., Clark R.A., Gehad A., Baecher-Allan C.M., Kupper T.S. 2012. Human epidermal Langerhans cells maintain immune homeostasis in skin by activating skin resident regulatory T cells. Immunity 36: 873-884.
• [31] Ghannoum M., Jurevic R.J., Mukherjee P.K., Cui F., Sikaroodi M., Naqvi A., Gillevet P.M. 2010. Characterization of the oral fungal microbiome (mycobiome) in healthy individuals. PLOS Pathogens 6: e1000713. doi:10.1371/journal.ppat.1000713.
• [32] Dupuy A.K., David M.S., Li Lu., Heider T.N., Peterson J.D., Montano E.A., Dongari-Bagtzoglou A., Diaz P.I., Strausbaugh L.D. 2014. Redefining the human oral mycobiome with improved practices in amplicon-based taxonomy: discovery of Malassezia as a prominent commensal. PLoS ONE doi:10.1371/journal.pone.0090899.
• [33] Mukherjee P.K., Chandra J., Retuerto M., Sikaroodi M., Brown R.E., Jurevic R., Salata R.A. Lederman M.M., Gillevet P.M., Ghannoum M.A. 2014. Oral mycobiome analysis of HIV-infected patients: identification of Pichia as an antagonist of opportunistic fungi. PLoS Pathogens 10: e1003996.
• [34] Foster M.L., Dowd S.E., Stephenson C. 2013. Characterization of the fungal microbiome mycobiome in fecal samples from dogs. Veterinary Medicine International 2013: 1-8.
• [35] Suchodolski J.S. 2011. Companion animals symposium: microbes and gastrointestinal health of dogs and cats. Journal of Animal Science 89: 1520-1530.
• [36] Pothoulakis C. 2009. Anti-inflammatory mechanisms of action of Saccharomyces boulardii. Alimentary Pharmacology and Therapeutics 30: 826-833.
• [37] Peterson C.T., Sharma V., Elmen L., Peterson S.N. 2015. Immune homeostasis, dysbiosis and therapeutic modulation of the gut microbiota. Clinical and Experimental Immunology 179: 363-377.
• [38] Rescigno M. 2011. The intestinal epithelial barrier in the control of homeostasis and immunity. Trends in Immunology 32: 256-264.
• [39] Charlson E.S., Diamond J.M., Bittinger K., Fitzgerald A.S., Yadav A., Haas A.R., Bushman F.D., Collman R.G. 2012. Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant. American Journal of Respiratory and Critical Care Medicine 186: 536-545.
• [40] Pragman A.A., Kim H.B., Reilly C.S., Wendt C., Isaacson R.E. 2012. The lung microbiome in moderate and severe chronic obstructive pulmonary disease. PLOS ONE 7: e47305.
• [41] Ramsey J.P., Reinert L.K., Heper L.K., Woodhams D.C., Rollins-Smith L.A. 2010. Immune defenses against Batrachochytrium dendrobatidis, a fungus linked to global amphibian declines, in the South African clawed frog Xenopus laevis. Infection and Immunity 78: 3981-3992.

Identyfikatory

DOI

10.17420/ap6203.51